Company Comparison
Fulcrum Therapeutics vs AI Therapeutics
Side-by-side comparison of two portfolio companies — sector, funding stage, investors, valuation, and more.
| Metric | Fulcrum Therapeutics | AI Therapeutics |
|---|---|---|
| Sector | Biotech | Biotech |
| Headquarters | Cambridge, Massachusetts | San Diego |
| Founded | 2016 | — |
| Status | Active | Active |
| Last Funding Stage | IPO | Series A |
| Total Funding | $200M | $48M |
| Valuation | — | — |
What They Build
Fulcrum Therapeutics
Clinical-stage biopharmaceutical company developing small molecule drugs for genetically defined diseases using gene modulation approach.
AI Therapeutics
A San Diego biotech company using AI to accelerate drug discovery and development processes.
Key Investors
Fulcrum Therapeutics
AI Therapeutics
No investors listed.
Sector Overlap
Both Fulcrum Therapeutics and AI Therapeutics operate in Biotech.
Browse all Biotech companies →Websites
The operating system for private capital.
Archstone runs the back office for venture, PE, real estate, and credit funds — LP reporting, capital calls, portfolio tracking, and fund accounting, in one platform. Now in alpha.
Now in alpha with select funds. 14-day trial available.